CN110585331A - 一种桑葚助眠膏及制备方法 - Google Patents
一种桑葚助眠膏及制备方法 Download PDFInfo
- Publication number
- CN110585331A CN110585331A CN201910849612.0A CN201910849612A CN110585331A CN 110585331 A CN110585331 A CN 110585331A CN 201910849612 A CN201910849612 A CN 201910849612A CN 110585331 A CN110585331 A CN 110585331A
- Authority
- CN
- China
- Prior art keywords
- sleep
- mulberry
- parts
- aiding
- paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000000249 Morus alba Species 0.000 title claims abstract description 59
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims description 13
- 239000000203 mixture Substances 0.000 claims description 61
- 239000002994 raw material Substances 0.000 claims description 19
- 244000197580 Poria cocos Species 0.000 claims description 17
- 235000008599 Poria cocos Nutrition 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 244000068988 Glycine max Species 0.000 claims description 10
- 235000010469 Glycine max Nutrition 0.000 claims description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 10
- 241000234435 Lilium Species 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 229920003169 water-soluble polymer Polymers 0.000 claims description 9
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 8
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 8
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 8
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 5
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 5
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 5
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 240000001008 Dimocarpus longan Species 0.000 claims description 4
- 235000000235 Euphoria longan Nutrition 0.000 claims description 4
- 235000012907 honey Nutrition 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 11
- 230000036541 health Effects 0.000 abstract description 9
- 230000003750 conditioning effect Effects 0.000 abstract description 4
- 238000004321 preservation Methods 0.000 abstract 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 57
- 206010022437 insomnia Diseases 0.000 description 53
- 230000000694 effects Effects 0.000 description 22
- 210000002216 heart Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 230000007958 sleep Effects 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000031971 Yin Deficiency Diseases 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000001431 Psychomotor Agitation Diseases 0.000 description 5
- 206010038743 Restlessness Diseases 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 230000008506 pathogenesis Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000004622 sleep time Effects 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 208000000044 Amnesia Diseases 0.000 description 3
- 208000031091 Amnestic disease Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- 208000036119 Frailty Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 240000008866 Ziziphus nummularia Species 0.000 description 3
- 230000006986 amnesia Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000020016 psychiatric disease Diseases 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010062519 Poor quality sleep Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 235000002723 Dioscorea alata Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027590 Middle insomnia Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000004620 sleep latency Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000008539 xiaoyao Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Neurosurgery (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明实施例提供了一种桑葚助眠膏及制备方法,本发明实施例的桑葚助眠膏,养心益肝,安神助眠,适用于失眠多梦、心烦不安、烦渴虚汗和健忘等人群,该桑葚助眠膏药物成分浓度高,体积小,易存储和携带,同时服用方便,口感较好,可以针对人整体进行调理,攻补兼施,集治病养生保健于一体,该桑葚助眠膏的制备方法,通过多次煎煮、滤液合并的形式,制备得到的膏方药物成分浓度大,药材利用率高。
Description
技术领域
本发明属于食品保健技术领域,具体涉及一种桑葚助眠膏及制备方法。
背景技术
失眠是一种常见的睡眠障碍,通常指患者对睡眠时间和/或质量不满足并影响白天社会功能的一种主观体验。近年来,随着人们生活方式的改变,社会竞争压力的增加,生活节奏的加快,失眠患者的数量急剧增加。据国外有关研究报告,人群中慢性失眠和严重失眠的发病率在10~35%之间。失眠虽然不属危急重症疾病范畴,但对人们的日常生活、工作和身心健康造成严重影响。失眠的系列症状没有得到有效控制时,患者将增加抑郁障碍和焦虑障碍的发生,甚至诱发或加重心脑血管等疾病。因此,失眠是值得关注的医学问题和社会问题。
中医学认为,失眠的病因病机复杂,多与心、脾、肝、肾等脏腑的功能失调有关,病理因素多归于火、痰、淤。忧思劳倦、内伤心脾、心肾不交、阴虚火旺、脾胃不和等都可以导致心神受累而诱发失眠。失眠总的发病机制是阳盛阴衰、阴阳失衡,临床上可分为虚、实两大类。失眠在《内经》中被称为“目不瞑”、“不得眠”、“不得卧”。《内经》在阴阳学说的整体观指导下,创立了卫气循行经络脏腑昼夜各二十五度以主持寤寐生理活动的理论,认为失眠的病机主要有卫气运行失常、胃气不和、水气上逆、火热扰心、气血虚衰等方面。《伤寒论》对失眠的论述分为两类:一是失治误治,伤及人体气血阴阳;二是除邪未尽,余热扰神。《金匮要略》中对不寐病因病机最经典的论述是《金匮要略·血痹虚劳病篇》“虚劳虚烦不得眠,酸枣仁汤主之”。酸枣仁汤具有养血安神,清热除烦之效,用于肝阴不足,心血亏虚之失眠。肝藏魂,肝阴不足,魂失归藏而不寐;阴虚则生内热,心血虚则血不养心,热扰心神,故虚烦不得眠。不寐作为兼见症状时的病因病机主要有:(1)心肺阴虚,热扰心神;(2)湿热内蕴,胃腑不和;(3)心阳不振,水气凌心;(4)寒聚胸膈,营卫不和;(5)血虚误汗,心神失养;(6)阴竭阳浮,阴不敛阳。《景岳全书》指出“不寐病虽病有不一,然惟知邪正二字则尽之。”
与西药治疗失眠相比,中医通过辩证论治可调整人体脏腑阴阳气血的功能,常能明显改善睡眠状况,而且不会产生药物成瘾性,具有一定的优势。中医失眠的辩证论治研究,包括从脏腑论治、从心论治、从肝胆论治、从脾胃论治、从脑论治、从气血论治、从阴阳论治等。后世历代医家在此基础上不断继承发展,在理论与临床实践方面都积累了丰富经验,产生了一系列辩证论治失眠的有效方药,如酸枣仁汤、归脾汤、温胆汤、逍遥散和血府逐瘀汤等,虽然上述方药为后世临床广泛应用并不断发展创新,然而汤剂方药入口苦、服用不便,不利于日常服用和推广。
发明内容
为解决现有技术中存在的问题,本发明实施例之一的目的在于提供一种桑葚助眠膏。本发明实施例之二的目的在于提供上述桑葚助眠膏的制备方法。
为实现上述目的,本发明实施例采用以下技术方案:
一种桑葚助眠膏,包括第一组合物和第二组合物,所述第一组合物和第二组合物的质量比为(1~2):1;
所述第一组合物包括以下重量份计的原料:
桑葚:200~400份;
所述第二组合物包括以下重量份计的原料:
百合:100~300份,
茯苓:100~300份,
淡豆豉:100~300份,
甘草:100~300份。
膏方,又名膏滋、膏剂,是中医传统八大剂型膏、丹、丸、散、酒、露、汤、锭之一。中医膏方是根据中医理论的组方法度,在辩证的基础上,按君臣佐使的原则,结合个人的治疗和保健需求,组成一个适宜于熬制膏剂的方剂,经一定工艺加工成半流质或半固体的制剂。本发明实施例的桑葚助眠膏,养心益肝,安神助眠,适用于失眠多梦、心烦不安、烦渴虚汗和健忘等人群,该桑葚助眠膏药物成分浓度高,体积小,易存储和携带,同时服用方便,口感较好,药力缓和,稳定持久,针对人整体进行调理,攻补兼施,集治病养生保健于一体。
上述膏方中,桑葚的主要营养成分有水分、糖分、粗蛋白、灰分、粗纤维、游离酸、可溶性无氮物等,此外,桑葚中还含有人体必需氨基酸及易于吸收的多糖、丰富的维生素、红色素及人体缺乏的钙、铁、锌、硒等矿物质,具有增强免疫力、促进造血细胞的生长、促进新陈代谢等作用,具有丰富的营养价值和药理学价值。桑葚入药,始载于唐朝的《唐本草》。中医认为,桑葚味甘性寒,人心肝、肾经,有滋阴补血作用,并能治阴虚津少、失眠等。另据许多古典中医文献记载:利五脏关节,通血气,安魂镇神,降压消渴,令人聪目,变白不老,解中酒毒等功效。现代医学临床证明:桑葚有很好的滋补心、肝、肾,及养血祛风的功效。对降脂和减轻神经衰弱、动脉硬化、性功能衰弱、耳聋眼花、须发早白、内热消渴、血虚便秘、风湿关节疼痛均有显著疗效。药理研究表明:桑葚入胃能补充胃液的缺乏,促进胃液的消化,人肠能促进肠液分泌,增进胃肠蠕动,因而有补益强壮之功。
百合除含有蛋白质、脂肪、还原糖、淀粉、钙、磷、铁、维生素B、维生素C等营养素外,还含有一些特殊的营养成分,如秋水仙碱等多种生物碱。这些成分综合作用于人体,不仅具有良好的营养滋补之功,而且还对秋季气候干燥而引起的多种季节性疾病有一定的防治作用。中医上讲鲜百合具有养心安神,润肺止咳的功效,对病后虚弱的人非常有益。
茯苓用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。
淡豆豉为豆科植物大豆的成熟种子的发酵加工品,其性味苦寒,具有解表,除烦,宣郁,解毒之功效。用于伤寒热病,寒热,头痛,烦躁,胸闷。
甘草具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药之功效。常用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
优选地,包括重量份计的辅料200~1000份。
进一步优选地,所述辅料包括蜂蜜和红糖中的至少一种。
优选地,所述第一组合物包括重量份计的山药200~400份。
进一步优选地,所述第一组合物包括重量份计的酸枣仁200~400份。
更进一步优选地,所述第一组合物包括重量份计的龙眼肉200~400份。
上述桑葚助眠膏的制备方法,步骤包括:
S1:按配比称取各原料,混合浸泡后进行第一次煎煮,过滤后得第一滤液和第一滤渣;
S2:将步骤S1的第一滤渣加水进行第二次煎煮,过滤后得第二滤液和第二滤渣;
S3:合并所述第一滤液和第二滤液后第一次加热浓缩,得浸膏;
S4:向步骤S3的浸膏中加入辅料后第二次加热浓缩,即得所述桑葚助眠膏。
优选地,步骤S1所述浸泡的时间大于30min。
优选地,步骤S1所述第一次煎煮的时间为1.5~2.5h。
进一步优选地,步骤S1所述第一次煎煮的时间为2h。
优选地,步骤S2所述第二次煎煮的时间为1.0~2.0h。
进一步优选地,步骤S2所述第二次煎煮的时间为1.5h。
本发明的有益效果
1、本发明实施例的桑葚助眠膏,养心益肝,安神助眠,适用于失眠多梦、心烦不安、烦渴虚汗和健忘等人群,该桑葚助眠膏药物成分浓度高,体积小,易存储和携带,同时服用方便,口感较好,可以针对人整体进行调理,攻补兼施,集治病养生保健于一体;
2、本发明实施例的桑葚助眠膏的制备方法,通过多次煎煮、滤液合并的形式,制备得到的膏方药物成分浓度大,药材利用率高。
具体实施方式
本发明实施例的桑葚助眠膏,养心益肝,安神助眠,适用于失眠多梦、心烦不安、烦渴虚汗和健忘等人群,该桑葚助眠膏药物成分浓度高,体积小,易存储和携带,同时服用方便,口感较好,药力缓和,稳定持久,针对人整体进行调理,攻补兼施,集治病养生保健于一体。
以下是本发明的具体实施例,并结合实施例对本发明的技术方案作进一步的描述,但本发明并不限于这些实施例。
实施例1
本例提供了一种桑葚助眠膏,包括第一组合物和第二组合物,所述第一组合物和第二组合物的质量比为2:1;
所述第一组合物包括以下重量份计的原料:
桑葚:200份;
所述第二组合物包括以下重量份计的原料:
百合:100份,
茯苓:100份,
淡豆豉:100份,
甘草:100份。
实施例2
本例提供了一种桑葚助眠膏,包括第一组合物和第二组合物,所述第一组合物和第二组合物的质量比为4:3;
所述第一组合物包括以下重量份计的原料:
桑葚:400份;
所述第二组合物包括以下重量份计的原料:
百合:300份,
茯苓:300份,
淡豆豉:300份,
甘草:300份。
实施例3
本例提供了一种桑葚助眠膏,包括第一组合物和第二组合物,所述第一组合物和第二组合物的质量比为1.5:1;
所述第一组合物包括以下重量份计的原料:
桑葚:300份;
所述第二组合物包括以下重量份计的原料:
百合:200份,
茯苓:200份,
淡豆豉:200份,
甘草:200份。
实施例4
本例提供了一种桑葚助眠膏,包括第一组合物和第二组合物,所述第一组合物包括以下重量份计的原料:
桑葚:300份,
山药:300份;
所述第二组合物包括以下重量份计的原料:
百合:200份,
茯苓:200份,
淡豆豉:200份,
甘草:200份。
实施例5
本例提供了一种桑葚助眠膏,包括第一组合物和第二组合物,所述第一组合物包括以下重量份计的原料:
桑葚:300份,
山药:300份,
酸枣仁:300份;
所述第二组合物包括以下重量份计的原料:
百合:200份,
茯苓:200份,
淡豆豉:200份,
甘草:200份。
实施例6
本例提供了一种桑葚助眠膏,包括第一组合物和第二组合物,所述第一组合物包括以下重量份计的原料:
桑葚:300份,
山药:300份,
酸枣仁:300份,
龙眼肉300份;
所述第二组合物包括以下重量份计的原料:
百合:200份,
茯苓:200份,
淡豆豉:200份,
甘草:200份;
辅料400份,辅料为蜂蜜和红糖的等比例混合物。
实施例7
本例提供了桑葚助眠膏的制备方法,步骤包括:
S1:按配比称取各原料,混合浸泡后进行第一次煎煮,过滤后得第一滤液和第一滤渣;
S2:将步骤S1的第一滤渣加水进行第二次煎煮,过滤后得第二滤液和第二滤渣;
S3:合并所述第一滤液和第二滤液后第一次加热浓缩,得浸膏;
S4:向步骤S3的浸膏中加入辅料后第二次加热浓缩,即得所述桑葚助眠膏。
其中,步骤S1所述浸泡的时间大于30min。第一次煎煮的时间为2h。
步骤S2所述第二次煎煮的时间为1.5h。
测试例
临床常见的失眠形式有:(1)睡眠潜伏期延长:入睡时间30min以上;(2)睡眠维持障碍:夜间觉醒次数大于2次或凌晨早醒;(3)睡眠质量下降:睡眠浅、多梦;(4)总睡眠时间缩短:通常少于6h;(5)日间残留效应:次晨感到头昏、精神不振、嗜睡、乏力等。失眠也可分为“入睡性失眠”、“睡眠维持性失眠”和“早醒性失眠”,一般失眠患者,均为混合性失眠,往往同时存在上述二至三种表现。
国际上对失眠症的诊断主要参考3个标准,即睡眠障碍国际分类(ICSD)、精神障碍诊断和统计手册第四版(DSM-4)和精神与行为障碍分类(ICD-10)。国内失眠的诊断主要参考中国精神障碍诊断(CCMD-3)。失眠分为原发性失眠与继发性两类。原发性失眠,几乎以失眠为唯一的症状,包括难以入睡、睡眠不深、多梦、早醒、或醒后不易再睡、醒后不适感、疲乏或白天困倦等;具有失眠和极度关注失眠结果的优势观念;对睡眠数量、质量的不满,引起明显的苦恼或社会功能受损;至少每周发生3次,并至少已打1个月;排除躯体疾病或精神障碍症状导致的情况。继发性失眠,多由疼痛、焦虑、抑郁或其他可查证因素引起的失眠。
采用自愿原则,选取已被诊断为失眠但未使用任何药物的志愿者210例,分为7组,每组30例,实验组每天早晚服用采用实施例7的制备方法,根据实施例1~6的配方制得的桑葚助眠膏,对照组未服用桑葚助眠膏及其它药物。志愿者服用1个月后,根据《中药新药临床研究指导原则》对其效果进行统计,结果如表1所示。
表1
组别 | 治愈 | 显效 | 有效 | 无效 | 有效率/% |
服用实施例1的桑葚助眠膏 | 6人 | 14人 | 5人 | 5人 | 83.3 |
服用实施例2的桑葚助眠膏 | 10人 | 11人 | 6人 | 3人 | 90 |
服用实施例3的桑葚助眠膏 | 15人 | 10人 | 3人 | 2人 | 93.3 |
服用实施例4的桑葚助眠膏 | 18人 | 6人 | 5人 | 1人 | 96.7 |
服用实施例5的桑葚助眠膏 | 22人 | 6人 | 2人 | 0人 | 100 |
服用实施例6的桑葚助眠膏 | 25人 | 3人 | 2人 | 0人 | 100 |
对照组 | 0 | 0 | 4 | 26 | 13.33 |
《中药新药临床研究指导原则》将失眠的疗效分为4个等级:
临床治愈:睡眠时间恢复正常或夜间睡眠时间在6h以上,睡眠深沉,醒后精神充沛;
显效:症状明显好转,睡眠时间增加3h以上,睡眠深度增加;
有效:症状减轻,睡眠时间较前增加不足3h;
无效:治疗后失眠无明显改善或加重者。
从表1的结果可以看出,实施例6的桑葚助眠膏的志愿者,治愈人数最多,说明桑葚、山药、酸枣仁、龙眼肉、百合、茯苓、淡豆豉、甘草和辅料的膏方效果最好。
志愿者中,黄女士,为湘潭市中心医院职工,年纪34岁,自我感觉为失眠多梦,半夜多次醒来,睡眠严重不足,导致工作时精力不足,时常出错误等,经诊断为虚烦不眠,予以桑葚助眠膏治疗,睡前半小时服用,待服用半个月后,明显感觉到半夜醒来的次数变少了,睡眠质量也好多了;服用一个月后,可以一觉睡到天亮了,多梦的症状也少了,病人主动要求持续服用桑葚助眠膏,予以巩固治疗。黄女士的失眠好转情况在服用本发明实施例助眠膏的人群中十分常见。
Claims (10)
1.一种桑葚助眠膏,其特征在于,包括第一组合物和第二组合物,所述第一组合物和第二组合物的质量比为(1~2):1;
所述第一组合物包括以下重量份计的原料:
桑葚:200~400份;
所述第二组合物包括以下重量份计的原料:
百合: 100~300份,
茯苓: 100~300份,
淡豆豉: 100~300份,
甘草: 100~300份。
2.根据权利要求1所述的桑葚助眠膏,其特征在于,包括重量份计的辅料200~1000份。
3.根据权利要求2所述的桑葚助眠膏,其特征在于,所述辅料包括蜂蜜和红糖中的至少一种。
4.根据权利要求1所述的桑葚助眠膏,其特征在于,所述第一组合物包括重量份计的山药200~400份。
5.根据权利要求4所述的桑葚助眠膏,其特征在于,所述第一组合物包括重量份计的酸枣仁200~400份。
6.根据权利要求5所述的桑葚助眠膏,其特征在于,所述第一组合物包括重量份计的龙眼肉200~400份。
7.根据权利要求1~6任一项所述桑葚助眠膏的制备方法,其特征在于,步骤包括:
S1:按配比称取各原料,混合浸泡后进行第一次煎煮,过滤后得第一滤液和第一滤渣;
S2:将步骤S1的第一滤渣加水进行第二次煎煮,过滤后得第二滤液和第二滤渣;
S3:合并所述第一滤液和第二滤液后第一次加热浓缩,得浸膏;
S4:向步骤S3的浸膏中加入辅料后第二次加热浓缩,即得所述桑葚助眠膏。
8.根据权利要求7所述桑葚助眠膏的制备方法,其特征在于,步骤S1所述浸泡的时间大于30min。
9.根据权利要求7所述桑葚助眠膏的制备方法,其特征在于,步骤S1所述第一次煎煮的时间为1.5~2.5h。
10.根据权利要求7所述桑葚助眠膏的制备方法,其特征在于,步骤S2所述第二次煎煮的时间为1.0~2.0h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910849612.0A CN110585331A (zh) | 2019-09-09 | 2019-09-09 | 一种桑葚助眠膏及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910849612.0A CN110585331A (zh) | 2019-09-09 | 2019-09-09 | 一种桑葚助眠膏及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110585331A true CN110585331A (zh) | 2019-12-20 |
Family
ID=68858301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910849612.0A Pending CN110585331A (zh) | 2019-09-09 | 2019-09-09 | 一种桑葚助眠膏及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110585331A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113244333A (zh) * | 2021-07-05 | 2021-08-13 | 陕西白鹿制药股份有限公司 | 一种治疗失眠的组合物及其制备方法、应用 |
CN113678919A (zh) * | 2021-09-02 | 2021-11-23 | 衢州市衢江区廿里镇养和残疾人之家 | 一种姜糖茶及其制备方法 |
CN113881534A (zh) * | 2021-10-27 | 2022-01-04 | 辽宁腾鳌酒业有限公司 | 一种用于助眠的配制酒及其制备方法 |
CN114617237A (zh) * | 2020-12-10 | 2022-06-14 | 新疆林业测试中心 | 一种桑葚降糖膏及其制备方法 |
CN114831295A (zh) * | 2022-05-28 | 2022-08-02 | 巧家县佰意佳食品有限公司 | 一种蜜蔗桑葚膏及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101991765A (zh) * | 2009-08-20 | 2011-03-30 | 安徽奥来新能源有限公司 | 安神助眠膏 |
CN107496808A (zh) * | 2017-09-25 | 2017-12-22 | 魏增强 | 用于治疗神经衰弱的中药组合物及其制备方法 |
CN108042699A (zh) * | 2018-01-19 | 2018-05-18 | 山东仁迪生物工程集团有限公司 | 一种治疗失眠的药物组合物、制剂及其制备方法 |
CN108567888A (zh) * | 2017-10-11 | 2018-09-25 | 山西中医药大学 | 一种百苓膏及其制备方法 |
-
2019
- 2019-09-09 CN CN201910849612.0A patent/CN110585331A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101991765A (zh) * | 2009-08-20 | 2011-03-30 | 安徽奥来新能源有限公司 | 安神助眠膏 |
CN107496808A (zh) * | 2017-09-25 | 2017-12-22 | 魏增强 | 用于治疗神经衰弱的中药组合物及其制备方法 |
CN108567888A (zh) * | 2017-10-11 | 2018-09-25 | 山西中医药大学 | 一种百苓膏及其制备方法 |
CN108042699A (zh) * | 2018-01-19 | 2018-05-18 | 山东仁迪生物工程集团有限公司 | 一种治疗失眠的药物组合物、制剂及其制备方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114617237A (zh) * | 2020-12-10 | 2022-06-14 | 新疆林业测试中心 | 一种桑葚降糖膏及其制备方法 |
CN113244333A (zh) * | 2021-07-05 | 2021-08-13 | 陕西白鹿制药股份有限公司 | 一种治疗失眠的组合物及其制备方法、应用 |
CN113678919A (zh) * | 2021-09-02 | 2021-11-23 | 衢州市衢江区廿里镇养和残疾人之家 | 一种姜糖茶及其制备方法 |
CN113881534A (zh) * | 2021-10-27 | 2022-01-04 | 辽宁腾鳌酒业有限公司 | 一种用于助眠的配制酒及其制备方法 |
CN114831295A (zh) * | 2022-05-28 | 2022-08-02 | 巧家县佰意佳食品有限公司 | 一种蜜蔗桑葚膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110585331A (zh) | 一种桑葚助眠膏及制备方法 | |
CN104873745B (zh) | 一种治疗失眠的中药及制备方法 | |
CN103689563A (zh) | 一种有助于改善睡眠的养生保健食品配方及其制备方法 | |
CN112314819A (zh) | 一种改善睡眠的植物饮料及其制备方法 | |
CN103142873A (zh) | 一种治疗顽固性失眠的中药 | |
CN104663989A (zh) | 一种安神茶及其制备方法 | |
CN108355088A (zh) | 一种改善睡眠质量的酸枣仁药酒及其制备方法 | |
CN104225295B (zh) | 用于改善睡眠的组合物及其制备方法和应用 | |
CN105596551A (zh) | 一种具有缓解视疲劳功能的中药组合物及制备方法 | |
CN104017701B (zh) | 一种五脏衡通养生保健酒 | |
CN106361976A (zh) | 一种安神助眠养颜复方制剂及其制备方法 | |
CN108014259B (zh) | 一种改善睡眠的中药组合物及其片剂 | |
CN105031302A (zh) | 一种辅助治疗艾滋病免疫功能重建不全的中药组合物 | |
CN112439038A (zh) | 一种快速改善睡眠的药物 | |
CN103520253A (zh) | 一种治疗劳损虚损症的药物及其制备方法 | |
CN108478739A (zh) | 一种调节阴阳平衡的保健品及其制备方法 | |
CN115154548B (zh) | 一种用于增强机体免疫力的中药口服液 | |
CN107929644A (zh) | 一种治疗窦性心动过缓的中药组合物及其制备方法 | |
CN105943771A (zh) | 一种改善气郁化火证失眠的中药 | |
CN106266779A (zh) | 一种调节内分泌失调的中药 | |
CN105581231A (zh) | 一种长寿养生早餐粉 | |
CN112587623A (zh) | 安神助眠的中药组合物、含有该组合物的口服液及其制备方法和应用 | |
CN105343567B (zh) | 小儿安睡方 | |
CN111514272A (zh) | 调理特禀体质的中药组合物及食品 | |
CN111481633A (zh) | 一种治疗神经衰弱、失眠的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191220 |